Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Hong Kong · Delayed Price · Currency is HKD

17.14

-0.50 (-2.83%)

Sep 10, 2026, 11:59 AM HKT

HKG:1877 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,026	2,498	1,948	1,503	1,453	4,025
Revenue Growth	29.85%	28.23%	29.67%	3.38%	-63.89%	152.36%
Gross Profit	2,443	1,967	1,425	868.16	927.21	2,767
Operating Income	-467.98	-913.6	-1,354	-2,476	-2,763	-686.06
Net Income	-440.82	-875.17	-1,281	-2,283	-2,386	-720.91
Earnings Per Share	-0.43	-0.87	-1.30	-2.32	-2.60	-0.81
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025
China	2,775	2,273
Overseas	186.1	188.8
Total	2,990	2,462

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	3,696	3,216	2,933	3,788	6,015	3,507
Total Debt	5,914	4,145	2,931	1,789	1,322	628.19
Net Cash (Debt)	-2,218	-928.98	1.82	2,000	4,693	2,878
Net Cash Growth	-	-	-99.91%	-57.39%	63.05%	13.58%
Net Cash Per Share	-2.16	-0.92	0.00	2.03	5.12	3.23

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-258.74	-519.57	-1,434	-2,005	-1,775	-605.05
Capital Expenditures	-791.73	-768.3	-690.99	-832.57	-383.1	-901.77
Free Cash Flow	-1,050	-1,288	-2,125	-2,838	-2,158	-1,507
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	80.73%	78.75%	73.13%	57.78%	63.79%	68.74%
Operating Margin	-15.46%	-36.57%	-69.49%	-164.79%	-190.09%	-17.05%
Pretax Margin	-18.88%	-40.96%	-69.68%	-165.83%	-184.05%	-14.78%
Profit Margin	-14.57%	-35.03%	-65.75%	-151.97%	-164.16%	-17.91%
FCF Margin	-34.71%	-51.55%	-109.06%	-188.85%	-148.50%	-37.44%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	83.34	83.34	83.34	83.34	83.34
PS Ratio	9.60	12.47	11.96	23.89	39.36	14.08